NASDAQ : MASI
Masimo Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 179.95 USD (At close: Jun 9, 2026) · Market cap 9.42B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.42B |
| Enterprise Value | 9.78B |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 52.37M |
| Shares Outstanding | 52.37M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.50% |
| Owned by Institutions (%) | 88.52% |
| Float | 44.31M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 126.63 |
| Forward PE | 28.99 |
| PS Ratio | 6.05 |
| Forward PS | 5.69 |
| PB Ratio | 11.94 |
| P/TBV Ratio | 14.79 |
| P/FCF Ratio | 44.68 |
| P/OCF Ratio | 40.62 |
| PEG Ratio | 1.69 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 128.24 |
| EV / Sales | 6.28 |
| EV / EBITDA | 26.61 |
| EV / EBIT | 30.47 |
| EV / FCF | 46.39 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.68 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 1.29 |
| Debt / FCF | 2.30 |
| Interest Coverage | 10.53 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 24.99% |
| Return on Assets (ROA) | 10.20% |
| Return on Invested Capital (ROIC) | 22.18% |
| Return on Capital Employed (ROCE) | 24.38% |
| Weighted Average Cost of Capital (WACC) | 10.03% |
| Revenue Per Employee | $708,409 |
| Profits Per Employee | $34,682 |
| Employee Count | 2,200 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.71 |
Taxes
| Measure | Value |
|---|
| Income Tax | 58.70M |
| Effective Tax Rate | 21.31% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +4.64% |
| 50-Day Moving Average | 178.55 |
| 200-Day Moving Average | 155.90 |
| Relative Strength Index (RSI) | 74.84 |
| Average Volume (20 Days) | 998,029 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.73M |
| Short Previous Month | 3.88M |
| Short % of Shares Out | 7.12% |
| Short % of Float | 8.42% |
| Short Ratio (days to cover) | 4.93 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.56B |
| Gross Profit | 960.50M |
| Operating Income | 321.10M |
| Pretax Income | 275.50M |
| Net Income | 76.30M |
| EBITDA | 367.70M |
| EBIT | 321.10M |
| Earnings Per Share (EPS) | $1.42 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 124.60M |
| Total Debt | 485.90M |
| Net Cash | -361.30M |
| Net Cash Per Share | -$6.90 |
| Equity (Book Value) | 788.90M |
| Book Value Per Share | 15.07 |
| Working Capital | 545.10M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 232.00M |
| Capital Expenditures | -21.10M |
| Depreciation & Amortization | 46.60M |
| Net Borrowing | -197.90M |
| Free Cash Flow | 210.90M |
| FCF Per Share | $4.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 61.63% |
| Operating Margin | 20.60% |
| Pretax Margin | 17.68% |
| Profit Margin | 4.90% |
| EBITDA Margin | 23.59% |
| EBIT Margin | 20.60% |
| FCF Margin | 13.53% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | 0.81% |
| FCF Yield | 2.24% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $180.00 |
| Price Target Difference | 0.03% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 6.60% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.97 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |